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SUMMARY 
Objective: Characterize mycobacterial species 
causing pulmonary tuberculosis (PTB) at the 
Korle-Bu Teaching Hospital in Ghana.  
Design: Sputum smear positive samples, two (2) 
from 70 patients diagnosed as having tuberculosis, 
after they had consented, were collected from the 
Korle-Bu Teaching Hospital Chest Clinic between 
January and July 2003. 
Setting: Korle-Bu Teaching Hospital Chest Clinic, 
Accra. 
Results: Sixty-four mycobacterial isolates were 
obtained and confirmed as members of Mycobac-
terium tuberculosis complex by colonial morphol-
ogy and conventional biochemical assays. Forty-
seven (73%) were M. tuberculosis, the human 
strain, 2 (3%) M. bovis, the bovine strain, 13 
(20%) M. africanum I (West Africa type), and 2 
(3%) M. africanum II (East Africa type).  
Conclusion: The results indicate that, there are 
various strains causing PTB at the Korle-Bu 
Teaching Hospital and of great concern is M. bo-
vis, which mostly causes extra-PTB in humans but 
found to cause PTB in this study. This calls for the 
need to conduct a nationwide survey using both 
conventional and molecular techniques to charac-
terize various mycobacterial species causing TB in 
Ghana. This will result in better understanding of 
the various strains circulating in the country and 
inform individual TB treatment regimen especially 
the inclusion or exclusion of pyrazinamide. 
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Tuberculosis (TB), a disease of great antiquity 
continues to be a major public health problem 
worldwide. One-third of the world’s over six bil-
lion population is infected with the tubercle bacilli 
with over two million deaths annually1. 
 
The available data on TB in Ghana indicate that 
the disease burden is high and TB remains an im-
portant cause of major disability and death in the 
country2. With Ghana’s population of over 20 mil-
lion, The World Health Organization (WHO) es-
timates 44,041 new cases of all forms of TB in 
Ghana corresponding to a TB incidence rate of 211 
per 100,000 inhabitants of whom 19,285 are smear 
positive cases3. 
 
This upsurge of TB is attributed to factors such as 
HIV/AIDS, poverty, population growth, over-
crowding, malnutrition, stress, drugs and alcohol 
abuse, consumption of contaminated meat and 
milk and multi-drug resistant (MDR) TB.  
 
TB is known to be caused mainly by the mamma-
lian tubercle bacilli, Mycobacterium tuberculosis 
complex, which consists of closely related species. 
The species are M. tuberculosis, M. bovis, M.bovis 
Bacillus Calmette-Guérin (BCG), M. africanum, 
M. microti, M. canetti and M. pinnipedii4,5,6. M. 
tuberculosis principally causes TB in humans but 
can affect animals that have contact with infected 
humans. It causes mainly pulmonary type of TB 
but extra-pulmonary type has also been reported. 
M. bovis which causes bovine TB affects cattle, 
humans, sheep, goats, pigs and several other do-
mestic and wild animals. M. bovis BCG on the 
other hand is termed the vaccine strain and can 
cause disseminated BCG infection in vaccinated 
children7. M. africanum is considered to be an in-
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termediate species between M. tuberculosis and M. 
bovis, being closer to the latter8. The organism 
causes TB in humans and occasionally animals 
such as apes9. M. microti which is attenuated in 
humans is a member of the complex and termed 
the vole bacillus as it causes TB in voles (Microtus 
agrestis) and other small rodents such as hamsters, 
shrews, rats, mice, rabbits and guinea-pigs10. M. 
canetti is rarely seen but can cause TB in humans5 
whereas M. pinnipedii is described as the seal ba-
cillus for causing TB in fish-eating sea animals6.  
 
Differentiation within the complex is necessary for 
epidemiological purposes and some individual 
patient treatment11. However, in Ghana as in most 
developing countries, TB is mostly diagnosed by 
sputum smear microscopy (SSM) which cannot 
differentiate members of the complex. Routine 
acid-fast bacilli (AFB) culture and identification of 
isolates are not performed due to lack of well 
equipped laboratory facilities. With the establish-
ment of biosafety level 3 (P3) mycobacterial la-
boratory at Noguchi Memorial Institute for Medi-
cal Research (NMIMR), a study was initiated in 
2003 with the main objective of characterizing 
mycobacterial species causing pulmonary tubercu-
losis in patients attending the Korle-Bu Teaching 
Hospital Chest Clinic in Accra, Ghana. This was 
after ethical clearance was granted by the Insti-
tutes’ ethical review board on research. 
 
MATERIALS AND METHODS 
Sample Collection 
Sputum smear positive samples, two (2) from each 
patient diagnosed as having tuberculosis, after they 
had consented were collected from the Chest Clin-
ic of the Korle-Bu Teaching Hospital (KBTH) 
which acts as national referral clinic, between Jan-
uary and July 2003. Samples were taken from se-
venty patients into sterile plastic containers and 
transported immediately to the Bio-safety Level 3 
(P3) TB Laboratory at NMIMR for processing: 
microscopy, culture and identification.  
 
Sputum Smear Microscopy 
To be certain that the samples were positive; spu-
tum smear examination was performed once again 
by the Ziehl-Neelsen technique: 0.3% carbol fuch-
sin for 5 min, 20% sulphuric acid as a decolouriser 
for 5 min and 0.3% methylene blue as a counters-
tain for 1 min. 
 
Culture of Sputum Samples 
Culture Medium 
Two percent (2%) modified Ogawa egg medium 
(Kudoh medium) (which has an advantage over 
Lowenstein-Jensen medium in developing coun-
tries as centrifugation is not required) was pre-
pared according to Ogawa and Saba12 and Kudoh 
and Kudoh13. Since medium-containing glycerol 
favours the growth of M. tuberculosis but inhibits 
the growth of both M. bovis and M. africanum, 
another set of medium without glycerol but con-
taining 0.5% sodium pyruvate, which encourages 
the growth of M. bovis and M. africanum, was also 
prepared4. 
 
Pre-treatment of Sputum Sample 
One volume of 4% sodium hydroxide – a decon-
taminant, was added to 1 volume of the sputum 
sample and stirred with pipette to homogenize. In 
cases of heavy mucous sample, it was left for 
about 10 minutes to digest after the addition of the 
decontaminant. 
 
Inoculation, Incubation and Reading 
About 0.1ml of the pre-treated sample was inocu-
lated into 4 tubes: 2 tubes containing glycerol and 
the other 2 containing pyruvate. The inoculated 
slants were incubated at 37oC.  
 
The culture tubes were observed one week after 
incubation for rapid growers and at 4 weeks for 
slow growers. When visible colonies did not ap-
pear at 4th week, observation continued weekly 
until 8 weeks before declaring the culture negative. 
The growth that appeared as colony in the 4th 
week, was recorded as rough or smooth, eugonic 
or dysgonic, buff, white, yellow or orange. The 
actual numbers of colonies seen and counted were 
also recorded as well as contaminated tubes. 
 
Identification Tests 
Besides morphological observations, the following 
biochemical tests were performed on the isolates. 
All the identification tests were carried-out on sub-
cultured strains using fresh Ogawa slants. 
 
Para-Nitrobenzoic Acid (PNB) Susceptibility 
Test 
This was performed according to Tsukamura14 to 
differentiate members of M. tuberculosis complex 
from other mycobacterial strains. In brief, 0.1 ml 
of bacillary suspension prepared from 3-week old 
sub-culture was inoculated into 2 tubes of 
0.5mg/ml PNB-containing and PNB-free media 
and incubated at 37oC for 4 to 28 days. The tubes 
were observed on the 4th, 7th, 14th, 21st, and 28th 
days for visible growth of colonies or otherwise. 
No growth observed in any of the PNB containing 
tubes after the 28 days of incubation was indica-
tive of members of the M. tuberculosis complex. 
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Niacin Accumulation Test  
BBL Taxo TB Niacin Test Strips (Becton and 
Dickinson, USA), absorbent paper strips and TB 
Niacin Positive Test Control paper discs were used 
according to the manufacturers’ instruction. Four-
week old sub-cultures having at least 50-100 colo-
nies were used.  
 
About 2.5ml sterile distilled water was added to 
the culture and the surface growth gently punc-
tured using 1 ml sterile pipette to permit extraction 
of niacin. With the help of sterile transfer pipette, 
approximately 0.6ml of the fluid extract was care-
fully removed and transferred to the bottom of 
20x125 mm screw cap test tube. Negative control 
was also prepared. The strips were dropped with 
arrow downward into the tubes: positive and nega-
tive controls, test culture and stopper immediately. 
The colours of the extracts were then compared 
after 15 minutes. Niacin accumulation was indi-
cated by vivid appearance of a yellow colour in the 
extract.  
 
Nitrate Reduction to Nitrite Test  
BBL Taxo TB Nitrite Test Strips (Becton and 
Dickinson, USA), absorbent paper strips were also 
used according to the manufacturers’ instruction.  
Four-week old sub-cultures were used. About 0.5 
ml sterile distilled water was transferred to each 
test tube. Using a sterile 1ml pipette, two clumps 
of growth were removed from the culture tube and 
added to the distilled water and dispersed with the 
pipette. The strips were then transferred into the 
tubes and incubated at 37oC for 2 hours. The co-
lours of the top portion of the strips were noted 
immediately after the incubation. Positive and 
negative controls tests were also performed fol-
lowing the same procedure. Nitrate reduction to 
nitrite, was indicated by change of colour of the 
top portion of the test strip from white to dark 
blue. 
 
Thiophene Carboxylic Acid Hydrazide (TCH) 
Susceptibility Test 
This was performed according to Yates and 
Grange15. About 0.1 ml of bacillary suspension 
prepared from 3-week old sub-culture was inocu-
lated into 2 tubes of 0.5mg/ml TCH-containing 
and TCH-free Ogawa media and incubated at 37oC 
for 3 to 4 weeks. The tubes were observed on the 
4th, 7th, 14th, 21st, 28th days for visible growth of 
colonies indicating resistance or otherwise.  
 
Oxygen Preference Test 
Middlebrook 7H9 media rendered semisolid by 
addition of 0.1% agar were used according to 
Marks16. The test was performed to distinguish 
microaerophilic bacilli from strictly aerobic ones. 
About 0.2ml of bacillary suspension prepared from 
3- week old sub-culture was inoculated about 1cm 
below the media surface. The tubes were incubated 
at 37oC undisturbed for 18 days. Aerobic growth 
occurred near the surface of the culture tubes, ex-
tending about 5mm below it whereas microaero-
philic growth occurred as a band, about 10-20mm 
below the surface.  
 
Pyrazinamide (PZA) Susceptibility Test 
The procedure according to Wayne17 was fol-
lowed. In brief, 2 loopfuls of 3-week old sub-
culture colonies were inoculated into two Middle-
brook 7H11 agar containing 0.1mg/ml PZA and 
2mg/ml sodium pyruvate and incubated together 
with 2 control tubes at 37oC for 4 days. After-
wards, 1ml of freshly prepared solution of ferrous 
ammonium sulphate, 1% w/v in distilled water was 
added to each of the test and control media and left 
at room temperature for 30 minutes and results 
read. 
 
Pyrazinamidase positive was indicated by a pink 
band at the upper part of the butt of the tubes. 
 
RESULTS 
All the sputum samples were confirmed as AFB 
positive by SSM. With respect to culture, on the 
average, growth appears within 3-4 weeks of incu-
bation confirming the strains as slow growers. Of 
the 70 patients sample cultured, growth occurred 
in 64 of them, giving a recovery rate of 91%; of 
the remaining 6 samples, contamination was ob-
served in 3 and no growth declared in another 3 
after 8 weeks of incubation (Table 1). 
 
The colonial morphologies of forty-nine (49) iso-
lates were dry and rough with irregular margins, 
typical eugonic growth with buff pigmentation, all 
suggestive of M. tuberculosis or M. africanum 
type II. The morphologies of thirteen (13) isolates 
were smooth and dysgonic with buff pigmentation, 
suggestive of M. africanum I. The colonies of the 
remaining two (2) isolates were smooth and dys-
gonic with white pigmentation, suggestive of M. 
bovis.  
 
Enhanced growth of M. tuberculosis was observed 
in medium containing glycerol whereas apprecia-
ble growth of M. bovis and M. africanum was ob-
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Table 1 Pattern of sputum growth and contamina-
tion (n=70) 
 
Grading Number of 
Samples 




















No Growth  
Between 1-19 Colonies  
Between 20-100 Colonies  
Between 100-200 Colonies  
Between 200-500 Colonies 
More than 500 Colonies  
Quarter of the medium 
contaminated  
Half of the medium Con-
taminated                                                                                                                    
 
 
The identification of the isolates were confirmed 
by the biochemical assays as shown in summary in 
Table 2. 
DISCUSSION 
The present study confirmed the general observa-
tion that TB is caused mainly by the members of 
the M. tuberculosis complex as 47 (73%) of the 
isolates were found to be M. tuberculosis, 2 (3%) 
M. bovis, 13 (20%) M. africanum type I and 2 
(3%) M. africanum type II. M. bovis BCG strain 
was not among the isolates confirming the notion 
that its isolation is more common in children than 
adults who were the present study subjects. The 
results have also incriminated M. tuberculosis as 
the most prevalent causative agent of pulmonary 
TB at the Korle-Bu Teaching Hospital. The appre-
ciable number of isolates 13/64 (20%) found to be 
M. africanum type I support the assertion that this 
strain which phenotypically resembles M. bovis is 
commonly found in West Africa8. The type II 
which resembles M. tuberculosis and principally 
found in East Africa was found in 2 (3%) of the 
isolates. 
 
Although this study reports on characterization of 
only sixty-four isolates, the results reveal that there 
are various strains of mycobacteria causing pul-
monary tuberculosis in Ghana. This calls for typ-
ing of isolates as in addition to epidemiological 
importance, it may be useful for individual patient 
treatment as some of the strains such as M. bovis 
are naturally resistant to pyrazinamide18, one of the 
first-line anti-tuberculosis drugs used in the coun-
try. Previous studies on characterization of myco-
bacterial species causing pulmonary tuberculosis 
in Ghana and some West African countries indi-
cated the same trend but M. bovis was rarely iso-
lated. Van der Werf et al.19 looking at speciation of 
99 isolates from TB patients presenting at the 
Chest Clinic in the middle belt of Ghana found the 
presence of M. tuberculosis in 57 (57.6%) of the 
isolates and 42 (42.4%) were M. africanum. Lawn 
et al20. also reported speciation of 26 isolates as M. 
tuberculosis 24 (92%) and M. africanum 2 (8%). 
The two studies reported no M. bovis being iso-
lated. Dosso et al.21 in a nationwide survey in 
neighbouring Cote d’Ivoire in 1995-1996 con-
firmed the involvement of M. tuberculosis in 299 
isolates out of 320 (93.4%) and 21 (6.6%) as M. 
africanum. Here too M. bovis was not isolated. 
However, Niobe-Eyangoh et al.22 in Quest Prov-
ince of the Central African country of Cameroon 
analyzed 455 M. tuberculosis complex strains and 
had 41 (9%) being M. tuberculosis, 413 (90.8%) 
being M. africanum and 1 (0.2%) being M. bovis. 
None of the above-mentioned studies did charac-
terize M. africanum to type I and II. 
 
Table 2 Characterization of Mycobacterial Isolates (n=64) 
 
Strain No. (%) PNB Niacin Nitrate TCH Oxygen PZA 
 
M. tuberculosis  
   
M. bovis 
 
M. africanum I 
 

























































Key: No. = number of strains; PNB = susceptibility to para-nitrobenzoic acid; Niacin = niacin accumulation; Nitrate = nitrate reduction to nitrite; TCH = 
susceptibility to thiophene carboxylic acid hydrazide; Oxygen = oxygen preference; PZA = susceptibility to pyrazinamide; - = negative; + = positive; Res 
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The present report is the only study where M. bo-
vis has been isolated in Ghana from pulmonary TB 
patients and attempt also made to type M. afri-
canum. Cases caused by M. bovis have been asso-
ciated with extra-pulmonary TB23. Humans are 
infected by the organism from cattle and other 
ruminants kept for meat and milk production10. 
Cattle are mostly reared in the coastal and guinea 
savannah zones of the country where the preva-
lence of bovine TB is reportedly high23. In some of 
the communities, members live in close contact 
with their animals that may be infected. Human-to-
human transmission of M. bovis is limited and 
anecdotal as it is believed that pulmonary patients 
infected by M. bovis are less infectious as they 
eliminate fewer bacilli in their sputum than those 
infected by M. tuberculosis24. Although the study 
could not have data on occupation of patients as it 
is not routinely recorded in health facilities in 
Ghana, it is highly recommended to capture such 
data as farmers, veterinarians and slaughterhouse 
workers who are exposed to infected animals and 
handle lesioned carcases are at a higher risk of 
acquiring M. bovis infection through the aerogen-
ous or respiratory route. 
 
TB microscopy is the routine diagnostic tool used 
in Ghana to diagnose TB and once acid-fast bacilli 
are found treatment is initiated without any further 
assays. It is now imperative that a nationwide sur-
vey is conducted in all the ecological zones using 
both conventional and molecular techniques to 
characterize the various mycobacterial species 
causing both pulmonary and extra-pulmonary TB 
and also equip the four public health laboratories 
in the country to conduct mycobacteria culture and 
speciation. This will result in better understanding 
of the circulating strains in the country, inform 
individual TB treatment regimen especially the 
inclusion or exclusion of pyrazinamide11, and lead 
to effective National TB Control Programme. 
 
ACKNOWLEDGEMENT 
We would like to acknowledge the Infectious Dis-
eases Project of the Noguchi Memorial Institute 
for Medical Research (NMIMR) funded by the 
Japan International Cooperation Agency (JICA) 
and the Department for International Development 
(DFID) (contract number AG 2071) as part of the 
West African TB Research Initiative for their sup-
port of this study. We are also grateful to Dr. 
Sampson Aboagye, Head, Chest Clinic, KBTH 




1. World Health Organization, Global Tubercu-
losis Control Report 2000. 
 
2. National Tuberculosis Report. Ghana Health 
Service/Ministry of Health–TB Five-Year 
Strategic Plan 2001. 
 
3. World Health Organization, Global Tubercu-
losis Control Report 2005. 
 
4. Grange JM, Yates MD, De Kantor, IN. Guide-
lines for speciation within the Mycobacterium 
tuberculosis complex. WHO/EMC/ZOO/96/4 
1996. 
 
5. Van Soolingen D, Hoogenboezem T, de Haas 
PE, Hermans PW, Koedam MA, Teppema 
KS. A novel pathogenic taxon of Mycobacte-
rium tuberculosis complex, Canetti: characte-
rization of an exceptional isolate from Africa. 
Int J Syst Bacteriol 1997; 47: 1236-1245. 
 
6. Cousins D, Bastida R, Cataldi A, Quse V, 
Redrobe S, Dow S. Tuberculosis in seals 
caused by a novel member of the Mycobacte-
rium tuberculosis complex: Mycobacterium 
pinnipedii sp. nov. Int J Syst Evol Microbiol 
2003; 53: 1305-1314. 
 
7. Romanus V, Svensson A, Hallender HO. The 
impact of changing BCG coverage on tubercu-
losis incidence in Swedish born children be-
tween 1969 and 1989. Tubercle Lung Disease 
1992; 73: 150-161. 
 
8. Grange JM, Yates MD. Incidence and nature 
of human tuberculosis due to M.   africanum 
in South-East England 1977-1987. Epidem Inf 
1989; 103: 127-132. 
 
9. Thorel, M.F., 1980. Isolation of M. africanum 
from monkeys. Tubercle 1980: 61: 101-104. 
 
10. Moda G, Daborn CJ, Grange JM, Cosivi O. 
The zoonotic importance of Mycobacterium 
bovis. Review article. Tubercle and Lung Dis-
ease 1996; 77: 103-108. 
 
11. Parsons LM, Brosch R, Cole ST, Somoskovi 
A, Loder A, Bretzel G. Rapid and simple ap-
proach for identification of Mycobacterium 
tuberculosis complex isolates by PCR-based 





June 2007 K.K. Addo et al Causative agents of pulmonary TB 
 57
12. Ogawa T, Saba, K. On the quantitative culti-
vation of tubercle bacilli. Kekkaku 1949; 2: 
13-29. 
 
13. Kudoh S, Kudoh T. A simple technique for 
culturing tubercle bacilli. Bull WHO 1974; 51: 
71-82. 
 
14. Tsukamura M, Tsukamura S. Differentiation 
of Mycobacterium tuberculosis and Mycobac-
terium bovis by p-nitrobenzoic acid suscepti-
bility. Tubercle 45: 64-65. 
 
15. Yates MD, Grange JM. A study of the rela-
tionship between the resistance of Mycobacte-
rium tuberculosis to isonicotinic acid hydra-
zide (isoniazid) and to thiophen-2-carboxylic 
acid hydrazide. Tubercle 65: 295-299. 
 
16. Marks J. A system for the examination of tu-
bercle bacilli and other Mycobacteria. Tuber-
cle 57: 207-225 
 
17. Wayne LG. Simple pyrazinamide and urease 
tests for routine identification of Mycobacte-
ria. Am Rev Respir Dis 109: 147-151. 
 
18. WHO/IUATLD. Anti-Tuberculosis Drug Re-
sistance in the World. The Global Project on 
Anti-TB Drug Resistance Surveillance (Doc-
ument, WHO/TB/1997.229) 1997. 
 
19. Van der Werf TS, Groothuis DG, van Kinge-
ren B. High initial drug resistance in pulmo-
nary tuberculosis in Ghana. Tubercle 1989; 
70: 249-255. 
 
20. Lawn SD, Frimpong EH, Al-Ghusein H, 
Acheampong JW, Uttley, AHC, Butcher PD, 
Griffin GE. Pulmonary tuberculosis in Kuma-
si, Ghana: presentation, drug resistance, mole-
cular epidemiology and outcome of treatment. 
West Afri J of Med 2001; 20: 92-97.  
21. Dosso M, Bonard D, Msellati P, Doulhourou 
C, Vincent V, Peyre M, Traore M, Koffi K, 
Coulibaly IM. Primary resistance to anti-
tuberculosis drugs: a national survey con-
ducted in Cote d’Ivoire in 1995-1996. Intl J of 
Tubercus and Lung Dis 1999; 9: 805-809. 
 
22. Niobe-Eyangoh SN, Kuaban C, Sorlin P, Cu-
nin P, Thonnon J, Sola C, Rastogi N, Vincent 
V, Gutierrez MC. Genetic Biodiversity of My-
cobacterium tuberculosis Complex Strains 
with Pulmonary Tuberculosis in Cameroon. J 
of Clin Microbiol 2003: 41: 2547-2553. 
 
23. Bonsu OA, Laing E, Akanmori BD. Preva-
lence of tuberculosis in the Dangme-West dis-
trict of Ghana, public health implications. Ac-
ta Tropica 2000; 76: 9-14. 
 
24. Kovalyov GK. On the human tuberculosis due 
to Mycobacterium bovis. A review. Microbiol 
Immunol 1989; 33: 199-206. 
 
 
 
 
 
 
 
 
 
